Recent Articles

Long-Term Nerve Damage Possible after Chemotherapy for Breast Cancer

| September 19, 2017 | 0 Comments

Long-Term Nerve Damage Possible after Chemotherapy for Breast Cancer Many women who receive taxane-based chemotherapy to treat breast cancer experience long-term nerve damage, or peripheral neuropathy, data from a large clinical trial show.See Original Article

Continue Reading

FDA Approves Inotuzumab for Adults with B-Cell Acute Lymphoblastic Leukemia

| September 18, 2017 | 0 Comments

FDA Approves Inotuzumab for Adults with B-Cell Acute Lymphoblastic Leukemia FDA has approved inotuzumab (Besponsa®) for some adults with B-cell acute lymphoblastic leukemia (ALL). The approval covers patients with B-cell ALL whose disease has relapsed or is refractory to standard chemotherapy.See Original Article

Continue Reading

FDA Approves Olaparib as Maintenance Therapy for Recurrent Ovarian Cancer

| September 14, 2017 | 0 Comments

FDA Approves Olaparib as Maintenance Therapy for Recurrent Ovarian Cancer FDA has granted regular approval to olaparib tablets (Lynparza®) as maintenance treatment for patients with recurrent ovarian cancer who are having partial or complete responses to platinum-based chemotherapy.See Original Article

Continue Reading

Brain Cancer’s Cholesterol Addiction May Offer New Treatment Strategy

| September 12, 2017 | 0 Comments

Brain Cancer’s Cholesterol Addiction May Offer New Treatment Strategy Brain cancer cells are heavily dependent on a constant supply of cholesterol to survive, a new study suggests. And in mice with brain tumors, treatment with a cholesterol-depleting drug slowed tumor growth and improved survival.See Original Article FDA Approves New Use for Lenalidomide in Multiple Myeloma […]

Continue Reading

Forgoing Conventional Cancer Treatments for Alternative Medicine Increases Risk of Death

| September 12, 2017 | 0 Comments

Forgoing Conventional Cancer Treatments for Alternative Medicine Increases Risk of Death In a large study, patients with nonmetastatic breast, lung, or colorectal cancer who chose alternative therapies had substantially worse survival than patients who received conventional cancer treatments.See Original Article

Continue Reading

CAR T-Cell Therapy Approved for Some Children and Young Adults with Leukemia

| September 11, 2017 | 0 Comments

CAR T-Cell Therapy Approved for Some Children and Young Adults with Leukemia FDA has approved tisagenlecleucel (Kymriah™), a type of immunotherapy called CAR T-cell therapy, for some children and young adults with advanced acute lymphoblastic leukemia (ALL). See Original Article

Continue Reading

Pancreatic Organoids – A Conversation with Senthil Muthuswamy

| September 8, 2017 | 0 Comments

Pancreatic Organoids – A Conversation with Senthil Muthuswamy Pancreatic cancer organoids can be established from tumor biopsies more quickly and cheaply and with more success than patient-derived xenografts. The organoids mimic patient histopathology and may allow drugs to be optimized for precision medicine.See Original Article Special Spotlight: Levi A. Garraway, M.D., Ph.D., Receives Prestigious Jane […]

Continue Reading

CURE Scholar Spotlight – Dr. Donita Colette Brady

| September 7, 2017 | 0 Comments

CURE Scholar Spotlight – Dr. Donita Colette Brady Donita C. Brady, a Research Associate Senior at the Department of Pharmacology and Cancer Biology at Duke University, is investigating the role that copper plays in cell growth and tumor biology. Inspired by her mentor Christopher Counter, a cancer biologist, and Dennis Thiele, a copper biologist, at […]

Continue Reading

Welcome to the New Cancer.gov

| September 7, 2017 | 0 Comments

Welcome to the New Cancer.gov NCI has launched a new, dynamic, and easier-to-use version of NCI’s main websites, Cancer.gov and its counterpart in Spanish, Cancer.gov/espanol.See Original Article Which Patients Will Benefit from Immunotherapy for Cancer? Some Hints Emerge Researchers have identified a “genetic signature” in the tumors of patients with advanced melanoma who responded to […]

Continue Reading

Crizotinib Shows Promise for Childhood Cancers

| September 5, 2017 | 0 Comments

Crizotinib Shows Promise for Childhood Cancers In a small clinical trial, the drug crizotinib shrank tumors in children with cancers that have alterations in the ALK gene. See Original Article

Continue Reading